VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 128 filers reported holding VERVE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,863 | -30.3% | 2,780 | -1.4% | 0.00% | – |
Q2 2023 | $52,875 | +278189.5% | 2,820 | +111.9% | 0.00% | – |
Q1 2023 | $19 | -26.9% | 1,331 | 0.0% | 0.00% | – |
Q4 2022 | $26 | -99.9% | 1,331 | -0.2% | 0.00% | – |
Q3 2022 | $50,000 | +194.1% | 1,333 | +21.2% | 0.00% | – |
Q2 2022 | $17,000 | – | 1,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 2,008,809 | $26,636,807 | 17.30% |
Alphabet Inc. | 10,549,086 | $139,880,880 | 8.98% |
Casdin Capital, LLC | 2,954,710 | $39,179,455 | 4.34% |
MPM BioImpact LLC | 857,940 | $11,376,284 | 3.04% |
Saltoro Capital, LP | 66,500 | $881,790 | 0.79% |
ARK Investment Management | 5,200,567 | $68,959,525 | 0.53% |
Redmile Group, LLC | 809,777 | $10,737,643 | 0.51% |
Ikarian Capital, LLC | 2,413 | $3,199,638 | 0.38% |
Logos Global Management LP | 215,000 | $2,850,900 | 0.38% |
Nikko Asset Management Americas, Inc. | 2,147,243 | $28,429,497 | 0.34% |